Chief Business Officer

Oxford Vacmedix appoints Dr Nam Park as Chief Business Officer

The appointment of Dr Nam Park as Chief Business Officer brings further expertise in venture financing and capital markets to Oxford Vacmedix Oxford, UK – 16th January 2025 Press Release – Appointment of Dr Nam Park 16-Jan-25 Oxford Vacmedix (OVM), the UK-based biopharma company focused on development of therapeutic cancer vaccines, announced today that Dr Nam Park, who has extensive experience and knowledge of finance and science, will join the company’s Management Team as Chief B...
Read More
en_GBEnglish